Garrison J C, Haynes R C
J Biol Chem. 1975 Apr 25;250(8):2769-77.
The possibility that hormones control hepatic gluconeogenesis via the regulation of the rate of mitochondrial pyruvate carboxylation was investigated with the use of suspensions of liver cells isolated from fasted rats. The mitochondria prepared from liver cells were judged in good condition as they exhibited satisfactory phosphorus-oxygen and respiratory control ratios and transported Ca2+ and K+ ions in an energy-dependent manner. Addition of glucagon, epinephrine, or cyclic adenosine 3':5'-monophosphate to liver cells caused a 50 to 80% increase in the rate of glucose synthesis from lactate. When mitochondria were isolated from the cells after treatment with these agonists, they displayed 2- to 3-fold increases in the rate of pyruvate carboxylation, pyruvate decarboxylation, and pyruvate uptake. These mitochondrial changes are similar to those obtained in hepatic mitochondria prepared from intact, hormone-treated rats. The mitochondrial responses were specific for agents that stimulated gluconeogenesis; no response occurred with 5'-AMP or cyclic adenosine 2':3'-monophosphate. In the cell suspensions, the dose response curves for the activation of mitochondrial pyruvate metabolism and for increased glucose synthesis from L-lactate were coincident with four different agonists. The mitochondrial changes resulting from stimulation with glucagon developed in 1 to 2 min after the rise in cyclic adenosine 3':5'-monophosphate and occurred at least as early as the increase in the rate of gluconeogenesis. When the intracellular level of cyclic adenosine 3':5'-monophosphate returned to basal values, the rates of mitochondrial pyruvate carboxylation and glucose synthesis also declined to control levels. It is concluded that the rate of mitochondrial pyruvate metabolisms can be increased by hormones and cyclic nucleotides and that control of mitochondrial pyruvate carboxylation is an important regulatory site of hepatic gluconeogenesis.
利用从禁食大鼠分离的肝细胞悬液,研究了激素通过调节线粒体丙酮酸羧化速率来控制肝糖异生的可能性。从肝细胞制备的线粒体被判定状态良好,因为它们表现出令人满意的磷氧比和呼吸控制率,并以能量依赖的方式转运Ca2+和K+离子。向肝细胞中添加胰高血糖素、肾上腺素或环腺苷3':5'-单磷酸会使乳酸生成葡萄糖的速率增加50%至80%。在用这些激动剂处理后从细胞中分离出线粒体时,它们的丙酮酸羧化、丙酮酸脱羧和丙酮酸摄取速率增加了2至3倍。这些线粒体变化与从完整的、经激素处理的大鼠制备的肝线粒体中获得的变化相似。线粒体反应对刺激糖异生的药物具有特异性;5'-AMP或环腺苷2':3'-单磷酸无反应。在细胞悬液中,四种不同激动剂激活线粒体丙酮酸代谢和增加L-乳酸生成葡萄糖的剂量反应曲线是一致的。胰高血糖素刺激引起的线粒体变化在环腺苷3':5'-单磷酸升高后1至2分钟出现,至少与糖异生速率增加同时发生。当细胞内环腺苷3':5'-单磷酸水平恢复到基础值时,线粒体丙酮酸羧化和葡萄糖合成速率也下降到对照水平。结论是,激素和环核苷酸可增加线粒体丙酮酸代谢速率,线粒体丙酮酸羧化的控制是肝糖异生的一个重要调节位点。